Jining Xuejia Sewing Co., Ltd – Trademark Portfolio

Entity Type: 99

Jining Xuejia Sewing Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LUSTREC. The owner is based in Jining, Shandong.

No. 8, Qianmiao Village

Jiaxiang Street, Jiaxiang County

Jining, Shandong 272000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LUSTREC
LUSTREC
Registered 2024
LUSTREC
LUSTREC
Registered 2024

Trademark Classifications

Jining Xuejia Sewing Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Jining Xuejia Sewing Co., Ltd have?

Jining Xuejia Sewing Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Jining Xuejia Sewing Co., Ltd file in?

Jining Xuejia Sewing Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are Jining Xuejia Sewing Co., Ltd's most well-known trademarks?

Jining Xuejia Sewing Co., Ltd's registered trademark portfolio includes well-known marks such as LUSTREC. These are among 2 currently registered trademarks in the portfolio.

What is Jining Xuejia Sewing Co., Ltd's trademark registration success rate?

Jining Xuejia Sewing Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.